ProQR Therapeutics N.V. (PRQR)
USD 2.57
(-12.59%)
USD 2.57
(-12.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 21.1 Million | -68.5 Million | -26.01 Million | -47.06 Million | -43.97 Million | -30.68 Million |
| Net Income | -27.54 Million | -64.89 Million | -61.68 Million | -46.61 Million | -56.74 Million | -37.08 Million |
| Depreciation & Amortization | 2.46 Million | 2.52 Million | 2.32 Million | 2.35 Million | 2.05 Million | 992 Thousand |
| Deferred income taxes | -78 Thousand | 96 Thousand | 117 Thousand | 124 Thousand | 235 Thousand | 102 Thousand |
| Stock-based compensation | 3.1 Million | 2.86 Million | 6.21 Million | 7.83 Million | 9.1 Million | 3.22 Million |
| Change in working capital | 47.95 Million | -5.43 Million | 24.99 Million | -5.01 Million | 1.78 Million | 1.29 Million |
| Other non-cash items | -4.79 Million | -3.66 Million | 2.01 Million | -5.75 Million | -402 Thousand | 792 Thousand |
| Investing Cash Flow | 4.19 Million | -702 Thousand | -425 Thousand | -924 Thousand | -580 Thousand | -312 Thousand |
| Investments in PPE | -3.64 Million | -708 Thousand | -484 Thousand | -924 Thousand | -580 Thousand | -312 Thousand |
| Acquisitions | 58.77 Thousand | 5891.94 | 61.35 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 7.77 Million | 108.06 | -2353.00 | - | - | - |
| Financing Cash Flow | -2.22 Million | -30.89 Million | 136.83 Million | 14.5 Million | 50.19 Million | 88.64 Million |
| Debt repayment | -987.33 Thousand | -45.04 Million | -820 Thousand | -605 Thousand | -1.26 Million | -1.44 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 346.74 Thousand | 14.12 Million | 108.47 Million | 684.79 Thousand | 48.55 Million | 86.38 Million |
| Other Financing Activities | -1.58 Million | 34 Thousand | 29.17 Million | 14.42 Million | 2.91 Million | 2.26 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 48.95 Million | - | - | - | - | - |
| Cash at beginning of period | 94.5 Million | 187.52 Million | 75.83 Million | 111.95 Million | 105.58 Million | 48.09 Million |
| Cash at end of period | 119.02 Million | 94.77 Million | 187.52 Million | 75.83 Million | 111.95 Million | 105.58 Million |
| Capital Expenditure | -3.64 Million | -708 Thousand | -484 Thousand | -924 Thousand | -580 Thousand | -312 Thousand |
| Effect of forex changes on cash | 599 Thousand | 7.35 Million | 1.29 Million | -2.62 Million | 721 Thousand | -171 Thousand |
| Net cash flow / Change in cash | 24.51 Million | -92.74 Million | 111.68 Million | -36.11 Million | 6.37 Million | 57.48 Million |
| Free Cash Flow | 17.46 Million | -69.21 Million | -26.49 Million | -47.98 Million | -44.55 Million | -30.99 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.7 Million | -7.7 Million | -5.34 Million | -27.54 Million | -5.42 Million | -7.97 Million |
| Depreciation & Amortization | 714.59 Thousand | 695.06 Thousand | 709.32 Thousand | 2.46 Million | 642 Thousand | 594 Thousand |
| Deferred income taxes | -200 Thousand | 3000.00 | 5000.00 | -78 Thousand | -83 Thousand | 464 Thousand |
| Stock-based compensation | 628 Thousand | 736 Thousand | 802 Thousand | 3.1 Million | 444 Thousand | 765 Thousand |
| Change in working capital | -4.56 Million | -9.27 Million | 1.71 Million | 47.95 Million | -2 Million | -3.62 Million |
| Other non-cash items | 1.81 Million | 2.45 Million | -3.37 Million | -4.79 Million | -1.08 Million | -571 Thousand |
| Investing Cash Flow | -122.44 Thousand | -17.83 Million | 4.87 Million | 4.19 Million | -339 Thousand | -294 Thousand |
| Investments in PPE | -262.32 Thousand | -736.3 Thousand | -2.86 Million | -3.64 Million | -339 Thousand | -294 Thousand |
| Acquisitions | - | - | 12.13 Thousand | 58.77 Thousand | -22.42 | 663.52 |
| Investment purchases | 139.88 Thousand | -17.1 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 7.73 Million | 7.77 Million | 22.42 | -663.52 |
| Financing Cash Flow | -279.97 Thousand | -421.46 Thousand | -1.05 Million | -2.22 Million | -281 Thousand | -643 Thousand |
| Debt repayment | -294 Thousand | -581 Thousand | -1.29 Million | -987.33 Thousand | -432 Thousand | -647 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 10.72 Thousand | 162.95 Thousand | 192.15 Thousand | 346.74 Thousand | 155.39 Thousand | 3991.20 |
| Other Financing Activities | 12 Thousand | - | 48.17 Thousand | -1.58 Million | -4390.00 | 8.80 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -4.61 Million | - | - | - | - | - |
| Cash at beginning of period | 85.79 Million | 119.02 Million | 120.74 Million | 94.5 Million | 128.56 Million | 138.98 Million |
| Cash at end of period | 79.01 Million | 85.79 Million | 119.02 Million | 119.02 Million | 120.55 Million | 128.56 Million |
| Capital Expenditure | -262.32 Thousand | -736.3 Thousand | -2.86 Million | -3.64 Million | -339 Thousand | -294 Thousand |
| Effect of forex changes on cash | 62 Thousand | 71 Thousand | -213 Thousand | 599 Thousand | 118 Thousand | 860 Thousand |
| Net cash flow / Change in cash | -6.77 Million | -33.23 Million | -1.71 Million | 24.51 Million | -8.01 Million | -10.42 Million |
| Free Cash Flow | -6.42 Million | -15.95 Million | -8.35 Million | 17.46 Million | -7.84 Million | -10.64 Million |
NSA-PA
CU6
SPLIL
301181
PIG
GRHI